Trastuzumab MMAE | HER2 inhibitor | Read Reviews & Product Use Citations

Trastuzumab MMAE is an antibody-drug conjugate (ADC) composed of an anti-HER2 antibody, conjugated to Monomethyl Auristatin E (MMAE), via a Mc linker. Trastuzumab MMAE has the potential for use in research of solid tumors mainly in HER2-positive breast cancer.

CAS No.

Click to purchase products related to Trastuzumab MMAE

Purity & Quality Control

Batch: D405201 Purity: 98% Protein concentration: 3.15mg/ml Endotoxin Level: ＜1EU/mg

98

Choose Selective HER2 Inhibitors

Biological Activity

Description	Trastuzumab MMAE is an antibody-drug conjugate (ADC) composed of an anti-HER2 antibody, conjugated to Monomethyl Auristatin E (MMAE), via a Mc linker. Trastuzumab MMAE has the potential for use in research of solid tumors mainly in HER2-positive breast cancer.

References
[1] Abdollahpour-Alitappeh M, et al. J Cell Physiol. 2019 Mar;234(3):2693-2704.

References

[1] Abdollahpour-Alitappeh M, et al. J Cell Physiol. 2019 Mar;234(3):2693-2704.

Product Details

ADC antiody	Trastuzumab
ADC linker	Mc linker
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field